AxoGen, Inc.
AXGN
$49.23
-$1.17-2.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.57% | 22.41% | 20.21% | 18.72% | 17.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.57% | 22.41% | 20.21% | 18.72% | 17.17% |
| Cost of Revenue | 22.18% | 18.45% | 27.54% | 21.96% | 25.16% |
| Gross Profit | 24.05% | 23.78% | 17.87% | 17.66% | 14.64% |
| SG&A Expenses | 33.81% | 29.68% | 21.12% | 10.87% | 5.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 30.99% | 26.79% | 22.26% | 11.31% | 8.55% |
| Operating Income | -850.47% | -2,224.74% | -138.79% | 146.36% | 114.02% |
| Income Before Tax | -619.45% | -339.10% | -57.60% | 85.34% | 71.80% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -619.45% | -339.10% | -57.60% | 85.34% | 71.80% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -619.45% | -339.10% | -57.60% | 85.34% | 71.80% |
| EBIT | -850.47% | -2,224.74% | -138.79% | 146.36% | 114.02% |
| EBITDA | -169.00% | -132.55% | -125.36% | 689.23% | 242.94% |
| EPS Basic | -544.11% | -292.61% | -46.84% | 85.76% | 72.70% |
| Normalized Basic EPS | -231.70% | -89.57% | -46.80% | 85.80% | 72.71% |
| EPS Diluted | -535.20% | -297.70% | -50.24% | 83.40% | 72.38% |
| Normalized Diluted EPS | -228.44% | -89.71% | -47.01% | 85.17% | 72.38% |
| Average Basic Shares Outstanding | 10.18% | 7.54% | 5.11% | 5.04% | 4.05% |
| Average Diluted Shares Outstanding | 8.54% | 8.14% | 5.76% | 9.47% | 7.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |